Molecular Defects in Mastocytosis KIT and Beyond KIT

被引：67

作者：

Bibi, Siham ^{[1
]}

Langenfeld, Florent ^{[1
]}

Jeanningros, Sylvie ^{[1
]}

Brenet, Fabienne ^{[2
,3
,4
,5
]}

Soucie, Erinn ^{[2
,3
,4
,5
]}

Hermine, Olivier ^{[6
,7
,8
]}

Damaj, Gandhi ^{[8
,9
]}

Dubreuil, Patrice ^{[2
,3
,4
,5
,8
]}

Arock, Michel ^{[1
]}

机构：

[1] Ecole Normale Super, LBPA CNRS UMR8113, F-94235 Cachan, France

[2] Inserm U1068, CRCM, F-13009 Marseille, France

[3] Inst Paoli Calmettes, F-13009 Marseille, France

[4] Aix Marseille Univ, UM 105, F-13284 Marseille, France

[5] CNRS, CRCM, UMR7258, F-13009 Marseille, France

[6] Paris Descartes Univ, Fac Med, Dept Clin Hematol, F-75006 Paris, France

[7] Paris Descartes Univ, AP HP Necker Enfants Malades, F-75006 Paris, France

[8] Mastocytosis Reference Ctr, AP HP Necker Enfants Malades, Fac Med, F-75743 Paris 15, France

[9] CHU Amiens, Hop Sud, Dept Clin Hematol, F-80054 Amiens, France

来源：

IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA | 2014年 / 34卷 / 02期

关键词：

Systemic mastocytosis; KIT; Mutation; Signaling; TET2; ASXL1; Spliceosome; Targeted therapy; STEM-CELL FACTOR; HUMAN MAST-CELL; AGGRESSIVE SYSTEMIC MASTOCYTOSIS; LIGAND-INDEPENDENT ACTIVATION; RECEPTOR TYROSINE KINASE; PROTOONCOGENE C-KIT; GROWTH-FACTOR; PEDIATRIC MASTOCYTOSIS; CUTANEOUS MASTOCYTOSIS; COMPETENCE NETWORK;

D O I：

10.1016/j.iac.2014.01.009

中图分类号：

R392 [医学免疫学];

学科分类号：

100102 ;

摘要：

In all variants of mastocytosis, activating KIT mutations are frequently found. In adults, neoplastic mast cells (MCs) cells show the KIT mutation D816V, whereas in children, MCs invading the skin are frequently positive for non-KIT D816V mutations. The clinical course and prognosis of the disease vary among patients With systemic mastocytosis (SM). Additional KIT-independent molecular defects might cause progression. Additional oncogenic lesions have recently been identified in advanced SM. In advanced SM the presence of additional genetic lesions or altered signaling worsening the prognosis might lead to the use of alternative therapies such as combined antisignaling targeted treatments or stem cell transplantation.

引用

页码：239 / +

页数：26

共 118 条

[1] Role of TET2 and ASXL1 Mutations in the Pathogenesis of Myeloproliferative Neoplasms [J].

Abdel-Wahab, Omar ;

Mu, Ayalew Tefferi ;

Levine, Ross L. .

HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2012, 26 (05) :1053-+

[2] Treatment responses to cladribine and dasatinib in rapidly progressing aggressive mastocytosis [J].

Aichberger, K. J. ;

Sperr, W. R. ;

Gleixner, K. V. ;

Kretschmer, A. ;

Valent, P. .

EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2008, 38 (11) :869-873

[3] A novel form of mastocytosis associated with a transmembrane c-kit mutation and response to imatinib [J].

Akin, C ;

Fumo, G ;

Yavuz, AS ;

Lipsky, PE ;

Neckers, L ;

Metcalfe, DD .

BLOOD, 2004, 103 (08) :3222-3225

[4] Complete Response After Imatinib Mesylate Therapy in a Patient With Well-Differentiated Systemic Mastocytosis [J].

Alvarez-Twose, Ivan ;

Gonzalez, Pablo .

JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (12) :E126-E129

[5]

ANDERSON DM, 1991, CELL GROWTH DIFFER, V2, P373

[6] Pathogenesis, classification and treatment of mastocytosis: state of the art in 2010 and future perspectives [J].

Arock, Michel ;

Valent, Peter .

EXPERT REVIEW OF HEMATOLOGY, 2010, 3 (04) :497-516

[7] Therapeutic targeting of c-KIT in cancer [J].

Ashman, Leonie K. ;

Griffith, Renate .

EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2013, 22 (01) :103-115

[8] The biology of stem cell factor and its receptor C-kit [J].

Ashman, LK .

INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 1999, 31 (10) :1037-1051

[9] Expression of Activated STAT5 in Neoplastic Mast Cells in Systemic Mastocytosis [J].

Baumgartner, Christian ;

Cerny-Reiterer, Sabine ;

Sonneck, Karoline ;

Mayerhofer, Matthias ;

Gleixner, Karoline V. ;

Fritz, Richard ;

Kerenyi, Marc ;

Boudot, Cedric ;

Gouilleux, Fabrice ;

Kornfeld, Jan-Wilhelm ;

Sillaber, Christian ;

Moriggl, Richard ;

Valent, Peter .

AMERICAN JOURNAL OF PATHOLOGY, 2009, 175 (06) :2416-2429

[10] Pediatric Mastocytosis Is a Clonal Disease Associated with D816V and Other Activating c-KIT Mutations [J].

Bodemer, Christine ;

Hermine, Olivier ;

Palmerini, Fabienne ;

Yang, Ying ;

Grandpeix-Guyodo, Catherine ;

Leventhal, Phillip S. ;

Hadj-Rabia, Smail ;

Nasca, Laurent ;

Georgin-Lavialle, Sophie ;

Cohen-Akenine, Annick ;

Launay, Jean-Marie ;

Barete, Stephane ;

Feger, Frederic ;

Arock, Michel ;

Catteau, Benoit ;

Sans, Beatrix ;

Stalder, Jean Francois ;

Skowron, Francois ;

Thomas, Luc ;

Lorette, Gerard ;

Plantin, Patrice ;

Bordigoni, Pierre ;

Lortholary, Olivier ;

de Prost, Yves ;

Moussy, Alain ;

Sobol, Hagay ;

Dubreuil, Patrice .

JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2010, 130 (03) :804-815

← 1 2 3 4 5 6 7 8 9 10 →